{"id":19124,"date":"2019-04-09T14:14:17","date_gmt":"2019-04-09T14:14:17","guid":{"rendered":"https:\/\/genomecanada.ca\/drupal\/blog\/le-dr-eric-meslin-nous-parle-des-ge3ls\/"},"modified":"2022-05-02T13:48:24","modified_gmt":"2022-05-02T13:48:24","slug":"le-dr-eric-meslin-nous-parle-des-ge3ls","status":"publish","type":"post","link":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/","title":{"rendered":"Le Dr Eric Meslin nous parle des GE3LS"},"content":{"rendered":"

\"\"Eric M. Meslin, Ph.D., MACSS
\nPr\u00e9sident-directeur g\u00e9n\u00e9ral du Conseil des acad\u00e9mies canadiennes (CAC)<\/strong><\/p>\n

    \n
  1. Vous avez r\u00e9cemment pr\u00e9sid\u00e9 un comit\u00e9 d\u2019experts de G\u00e9nome Canada qui s\u2019est pench\u00e9 sur la strat\u00e9gie GE3<\/sup>LS int\u00e9gr\u00e9e de G\u00e9nome Canada. Pourquoi G\u00e9nome Canada a-t-il entrepris cet examen?\n
      \n
    • G\u00e9nome Canada a toujours \u00e9t\u00e9 un chef de file de GE3<\/sup>LS et comme le font (et devraient le faire) les organismes \u00e0 l\u2019avant-sc\u00e8ne, il a voulu \u00e9tudier attentivement un aspect du portefeuille GE3<\/sup>LS g\u00e9n\u00e9ral, \u00e0 savoir l\u2019efficacit\u00e9 avec laquelle la recherche GE3<\/sup>LS int\u00e9gr\u00e9e a facilit\u00e9 l\u2019application de la recherche en g\u00e9nomique. Autrement dit, le comit\u00e9 \u00e9value l\u2019utilit\u00e9 de la recherche GE3<\/sup>LS dans les projets scientifiques en g\u00e9nomique. Nous savons depuis un certain temps que le simple fait de placer un chercheur GE3<\/sup>LS dans un laboratoire n\u2019a pas n\u00e9cessairement beaucoup d\u2019influence. La cl\u00e9, c\u2019est de d\u00e9terminer ce qui fonctionne le mieux et les obstacles \u00e0 une int\u00e9gration r\u00e9ussie. <\/li>\n<\/ul>\n<\/li>\n
    • Bri\u00e8vement, quelles ont \u00e9t\u00e9 les conclusions du comit\u00e9 d\u2019experts?\n
        \n
      • Nous avons conclu que le mod\u00e8le GE3<\/sup>LS a encore beaucoup \u00e0 offrir, mais il ne faut pas le limiter \u00e0 ces premiers succ\u00e8s. G\u00e9nome Canada doit faciliter la collaboration entre les chercheurs GE3<\/sup>LS et les chercheurs en g\u00e9nomique, accro\u00eetre la capacit\u00e9 de GE3<\/sup>LS, en particulier en partenariat avec les centres de g\u00e9nomique, et souligner la valeur de GE3<\/sup>LS en approfondissant son r\u00f4le de chef de file national \u00e0 cet \u00e9gard. Le Canada a une mine de \u00ab ressources \u00bb dans ce domaine; il faut les faire conna\u00eetre et les utiliser largement.<\/li>\n<\/ul>\n<\/li>\n
      • De nombreuses personnes ne pensent peut-\u00eatre pas \u00e0 la g\u00e9nomique en g\u00e9n\u00e9ral, ni \u00e0 G\u00e9nome Canada en particulier en tant qu\u2019organisme subventionnaire des sciences sociales\/humaines, mais la recherche GE3<\/sup>LS est v\u00e9ritablement interdisciplinaire. Pourquoi cette approche multidisciplinaire est-elle importante pour la g\u00e9nomique?\n
          \n
        • Depuis les tout premiers jours du Projet du g\u00e9nome humain, on a largement reconnu et appuy\u00e9 la n\u00e9cessit\u00e9 de la recherche pour pr\u00e9voir et r\u00e9soudre les probl\u00e8mes d\u2019ordre \u00e9thique, l\u00e9gal et social. Ces connaissances sont pr\u00e9cieuses \u00e0 de nombreux \u00e9gards, car elles aident les chercheurs en g\u00e9nomique \u00e0 concevoir de meilleures \u00e9tudes; les cliniciens \u00e0 mieux comprendre comment parler des risques et des avantages des tests g\u00e9n\u00e9tiques avec les patients; et les investisseurs, les organismes de r\u00e9glementation et les d\u00e9cideurs \u00e0 promouvoir l\u2019adoption responsable de la g\u00e9nomique au profit de la soci\u00e9t\u00e9. Le g\u00e9nie v\u00e9ritable de l\u2019approche GE3<\/sup>LS a \u00e9t\u00e9 de montrer le r\u00f4le indispensable des sciences humaines et sociales comme partenaires de la cog\u00e9n\u00e9ration de nouvelles connaissances et pas simplement, un beau logo \u00e0 ajouter \u00e0 l\u2019en-t\u00eate.<\/li>\n<\/ul>\n<\/li>\n
        • Y a-t-il quelque chose de typiquement canadien dans l\u2019espace GE3<\/sup>LS?\n
            \n
          • \u00c0 mon avis, GE3<\/sup>LS a toujours \u00e9t\u00e9 l\u2019une des plus grandes contributions du Canada \u00e0 l\u2019effort mondial en g\u00e9nomique. Les \u00c9tats-Unis ont peut-\u00eatre \u00e9labor\u00e9 le premier programme sur les r\u00e9percussions \u00e9thiques, l\u00e9gales et sociales (ELSI) pour l\u2019examen de ces enjeux, mais l\u2019approche GE3<\/sup>LS canadienne est all\u00e9e plus loin de trois fa\u00e7ons : premi\u00e8rement, elle a \u00e9largi la conversation au-del\u00e0 de ces trois disciplines pour y inclure les enjeux \u00e9conomiques et environnementaux; deuxi\u00e8mement, elle ne se limite pas au financement de chercheurs dont les travaux ont trait \u00e0 leur propre discipline, elle finance aussi ceux qui collaborent activement et d\u00e9lib\u00e9r\u00e9ment avec les chercheurs en g\u00e9nomique; troisi\u00e8mement, elle n\u2019est pas limit\u00e9e aux questions de sant\u00e9 humaine, elle s\u2019\u00e9tend aussi \u00e0 tous les secteurs des plateformes de G\u00e9nome Canada, soit la foresterie, l\u2019aquaculture, l\u2019agriculture, l\u2019environnement, l\u2019\u00e9nergie et les mines.<\/li>\n<\/ul>\n<\/li>\n
          • Quel est le plus grand enjeu dont devront se pr\u00e9occuper les chercheurs en g\u00e9nomique au cours de la prochaine d\u00e9cennie et comment la recherche GE3<\/sup>LS peut-elle y contribuer?\n
              \n
            • Un choix difficile! Il serait cependant \u00e9pineux de passer sous silence la collision entre l\u2019intelligence artificielle et la g\u00e9nomique. La rapidit\u00e9 de l\u2019innovation dans un domaine de l\u2019IA, l\u2019apprentissage machine, peut avoir des r\u00e9percussions profondes sur tout l\u2019environnement de la g\u00e9nomique et de la sant\u00e9, depuis les am\u00e9liorations dans les d\u00e9couvertes de g\u00e8nes de maladies rares \u00e0 la conception de nouveaux m\u00e9dicaments, en passant par les diagnostics. Les chercheurs GE3<\/sup>LS occupent une position id\u00e9ale pour faire ce qu\u2019ils font le mieux, c\u2019est-\u00e0-dire \u00ab cartographier \u00bb d\u2019abord le nouveau domaine et ensuite commencer \u00e0 \u00ab s\u00e9quencer \u00bb les enjeux. Autrement dit, d\u00e9terminer les enjeux, leur complexit\u00e9, puis commencer \u00e0 proposer des solutions qu\u2019il sera possible de mettre en \u0153uvre. L\u2019aspect fascinant de cette collision entre l\u2019IA et la g\u00e9nomique est la r\u00e9apparition d\u2019enjeux que nous connaissons d\u00e9j\u00e0, par exemple, le respect de la vie priv\u00e9e, la discrimination, l\u2019acc\u00e8s, la justice, le consentement, qui se retrouveront cependant dans un contexte o\u00f9 le changement survient tr\u00e8s rapidement dans d\u2019autres domaines : le travail, l\u2019expansion des entreprises, les finances, la s\u00e9curit\u00e9. L\u2019avenir sera tr\u00e8s palpitant et nous aurons besoin de toute l\u2019aide disponible.<\/li>\n<\/ul>\n<\/li>\n
            • Nous allons tous nous retrouver plus tard \u00e0 un karaok\u00e9. Quelle chanson chanterez-vous et pourquoi?\n
                \n
              • Facile. Les Doobie Brothers, \u00ab Takin\u2019 it to the Streets \u00bb.  (Je parie que je vous surprends!)<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                Eric M. Meslin, Ph.D., MACSS Pr\u00e9sident-directeur g\u00e9n\u00e9ral du Conseil des acad\u00e9mies canadiennes (CAC) Vous avez r\u00e9cemment pr\u00e9sid\u00e9 un comit\u00e9 d\u2019experts de G\u00e9nome Canada qui s\u2019est pench\u00e9 sur la strat\u00e9gie GE3LS int\u00e9gr\u00e9e de G\u00e9nome Canada. Pourquoi G\u00e9nome Canada a-t-il entrepris cet examen? G\u00e9nome Canada a toujours \u00e9t\u00e9 un chef de file de GE3LS et comme le […]<\/p>\n","protected":false},"author":8,"featured_media":19174,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[34],"tags":[],"mission-categories":[],"class_list":["post-19124","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\nLe Dr Eric Meslin nous parle des GE3LS - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le Dr Eric Meslin nous parle des GE3LS - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Eric M. Meslin, Ph.D., MACSS Pr\u00e9sident-directeur g\u00e9n\u00e9ral du Conseil des acad\u00e9mies canadiennes (CAC) Vous avez r\u00e9cemment pr\u00e9sid\u00e9 un comit\u00e9 d\u2019experts de G\u00e9nome Canada qui s\u2019est pench\u00e9 sur la strat\u00e9gie GE3LS int\u00e9gr\u00e9e de G\u00e9nome Canada. Pourquoi G\u00e9nome Canada a-t-il entrepris cet examen? G\u00e9nome Canada a toujours \u00e9t\u00e9 un chef de file de GE3LS et comme le […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-09T14:14:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-02T13:48:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genomecanada.ca\/wp-content\/uploads\/2019\/04\/ericmeslin.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nicola Katz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicola Katz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/\"},\"author\":{\"name\":\"Nicola Katz\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/person\\\/385bb861415d30d3ca126e8d1cd6fa93\"},\"headline\":\"Le Dr Eric Meslin nous parle des GE3LS\",\"datePublished\":\"2019-04-09T14:14:17+00:00\",\"dateModified\":\"2022-05-02T13:48:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/\"},\"wordCount\":950,\"publisher\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/ericmeslin.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/\",\"name\":\"Le Dr Eric Meslin nous parle des GE3LS - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/ericmeslin.jpg\",\"datePublished\":\"2019-04-09T14:14:17+00:00\",\"dateModified\":\"2022-05-02T13:48:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/#primaryimage\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/ericmeslin.jpg\",\"contentUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/ericmeslin.jpg\",\"width\":300,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/le-dr-eric-meslin-nous-parle-des-ge3ls\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le Dr Eric Meslin nous parle des GE3LS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/person\\\/385bb861415d30d3ca126e8d1cd6fa93\",\"name\":\"Nicola Katz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/debe39f1a3fba7bf4661dbd22e43f2ea7d5f37bc9ade4fb63802b66aa7b0c9b2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/debe39f1a3fba7bf4661dbd22e43f2ea7d5f37bc9ade4fb63802b66aa7b0c9b2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/debe39f1a3fba7bf4661dbd22e43f2ea7d5f37bc9ade4fb63802b66aa7b0c9b2?s=96&d=mm&r=g\",\"caption\":\"Nicola Katz\"},\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/author\\\/nicola\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le Dr Eric Meslin nous parle des GE3LS - GenomeCanada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/","og_locale":"fr_FR","og_type":"article","og_title":"Le Dr Eric Meslin nous parle des GE3LS - GenomeCanada","og_description":"Eric M. Meslin, Ph.D., MACSS Pr\u00e9sident-directeur g\u00e9n\u00e9ral du Conseil des acad\u00e9mies canadiennes (CAC) Vous avez r\u00e9cemment pr\u00e9sid\u00e9 un comit\u00e9 d\u2019experts de G\u00e9nome Canada qui s\u2019est pench\u00e9 sur la strat\u00e9gie GE3LS int\u00e9gr\u00e9e de G\u00e9nome Canada. Pourquoi G\u00e9nome Canada a-t-il entrepris cet examen? G\u00e9nome Canada a toujours \u00e9t\u00e9 un chef de file de GE3LS et comme le […]","og_url":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/","og_site_name":"GenomeCanada","article_published_time":"2019-04-09T14:14:17+00:00","article_modified_time":"2022-05-02T13:48:24+00:00","og_image":[{"width":300,"height":200,"url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2019\/04\/ericmeslin.jpg","type":"image\/jpeg"}],"author":"Nicola Katz","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Nicola Katz","Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/#article","isPartOf":{"@id":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/"},"author":{"name":"Nicola Katz","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/person\/385bb861415d30d3ca126e8d1cd6fa93"},"headline":"Le Dr Eric Meslin nous parle des GE3LS","datePublished":"2019-04-09T14:14:17+00:00","dateModified":"2022-05-02T13:48:24+00:00","mainEntityOfPage":{"@id":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/"},"wordCount":950,"publisher":{"@id":"https:\/\/genomecanada.ca\/fr\/#organization"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/#primaryimage"},"thumbnailUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2019\/04\/ericmeslin.jpg","articleSection":["News"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/","url":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/","name":"Le Dr Eric Meslin nous parle des GE3LS - GenomeCanada","isPartOf":{"@id":"https:\/\/genomecanada.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/#primaryimage"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/#primaryimage"},"thumbnailUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2019\/04\/ericmeslin.jpg","datePublished":"2019-04-09T14:14:17+00:00","dateModified":"2022-05-02T13:48:24+00:00","breadcrumb":{"@id":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/#primaryimage","url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2019\/04\/ericmeslin.jpg","contentUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2019\/04\/ericmeslin.jpg","width":300,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/genomecanada.ca\/fr\/le-dr-eric-meslin-nous-parle-des-ge3ls\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Le Dr Eric Meslin nous parle des GE3LS"}]},{"@type":"WebSite","@id":"https:\/\/genomecanada.ca\/fr\/#website","url":"https:\/\/genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/person\/385bb861415d30d3ca126e8d1cd6fa93","name":"Nicola Katz","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/debe39f1a3fba7bf4661dbd22e43f2ea7d5f37bc9ade4fb63802b66aa7b0c9b2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/debe39f1a3fba7bf4661dbd22e43f2ea7d5f37bc9ade4fb63802b66aa7b0c9b2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/debe39f1a3fba7bf4661dbd22e43f2ea7d5f37bc9ade4fb63802b66aa7b0c9b2?s=96&d=mm&r=g","caption":"Nicola Katz"},"url":"https:\/\/genomecanada.ca\/fr\/author\/nicola\/"}]}},"_links":{"self":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/posts\/19124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/comments?post=19124"}],"version-history":[{"count":0,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/posts\/19124\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/media\/19174"}],"wp:attachment":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=19124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/categories?post=19124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/tags?post=19124"},{"taxonomy":"mission-categories","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/mission-categories?post=19124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}